AzTrials
AzTrials

Malnourished ChildrenNCT07496801

Unveiling the Role of Intestinal Parasitic Infections in Childhood Malnutrition in Assiut Governorate.

An observational study of Malnourished Children, run by Assiut University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Official record
Search all trials

Trial summary

Intestinal parasitic infections (IPIs) are highly prevalent worldwide, particularly among children living in lowresource settings. (1) These infections pose a significant public health challenge due to their widespread distribution and their impact on vulnerable populations, especially preschool and school-aged… Read more about this study

Who is it for?
Ages 2 to 15 yearsHealthy volunteers can take part
Conditions the study is for
Malnourished Children
How many people
116 participants
Where
No sites listed yet
Study dates
Apr 2026to Dec 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 2 to 15 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: Malnourished children identified based on anthropometric measurements according to the growth standards of the World Health Organization. Height-for-Age, Weight-for-Age and Weight-for-Height were <-2 standard deviation (SD) were classified as stunted, wasted, and underweight, respectively.

Who may be able to join

  • Children aged 2-15 years of both sexes.
  • Children whose parents provide informed written consent.
  • Malnourished children identified based on anthropometric measurements according to the growth standards of the World Health Organization. Height-for-Age, Weight-for-Age and Weight-for-Height were <-2 standard deviation (SD) were classified as stunted, wasted, and underweight, respectively.
  • Apparently healthy control children of similar age groups

Who cannot join

  • • Children with chronic systemic diseases (e.g., chronic renal, hepatic, cardiac, or endocrine disorders).
  • Children with known genetic or congenital disorders affecting growth.
  • Children who received micronutrient supplementation (omega 3, zinc, vitamin D) within the last 3 months.
  • Children who received antiparasitic treatment within the last 3 months.

About this study

Intestinal parasitic infections (IPIs) are highly prevalent worldwide, particularly among children living in lowresource settings. (1) These infections pose a significant public health challenge due to their widespread distribution and their impact on vulnerable populations, especially preschool and school-aged children. (2) Common intestinal parasites include protozoa such as Giardia lamblia and Entamoeba histolytica, as well as helminths like Ascaris lumbricoides, Trichuris trichiura, and hookworms.(3) IPIs contribute to a range of health problems in children, including diarrhea, anemia, general weakness, and impaired physical development. These infections often cause malabsorption of nutrients and chronic blood loss, which can severely affect children's growth and overall health status. (2) Malnutrition has been defined by the World Health Organization as a major global health challenge with significant implications for morbidity and mortality worldwide.(4) It is characterized by conditions such as stunting, wasting, and underweight, all of which reflect inadequate nutrition and impaired growth. . (Yoseph \& Beyene, 2020).Malnutrition is influenced by multiple interconnected factors including socioeconomic status, inadequate feeding practices, lack of exclusive breastfeeding, recurrent infections, limited healthcare access, and poor environmental conditions such as unsafe water and sanitation. (5) Persistent and/or recurring IPIs are considered important contributors to adverse developmental outcomes depending on parasite species and infection dynamics.(6) They may contribute to malnutrition through both direct and indirect mechanisms. Directly, they can induce chronic subclinical systemic inflammation and modulate the host immune response to ensure persistence, resulting in adverse effects on growth.(7) For example, infection with Cryptosporidium spp.

has been linked to reduced length-for-age, mediated by increased systemic inflammation and decreased circulating IGF-1 concentrations.(8) Indirectly, they may promote environmental enteric dysfunction (EED), which is subclinical disorder of the small intestine that can contribute to malnutrition. It involves villous atrophy and crypt hyperplasia, reducing nutrient absorption, and infections such as G. lamblia may play a key role in its development.(6) Additionally IPIs may interact with the normal gut microbiota, with each influencing the other's pathogenic potential, and this interaction can contribute to malnutrition.(7) IPIs can reduce food intake by causing illness, abdominal discomfort, or altering appetite regulation.(8) They may affect neuroendocrine signals, modifying taste perception and satiety hormones, such as elevated leptin levels observed in children infected with E. histolytica, Strongyloides spp., and G. lamblia. Infections like Trichuris trichiura have also been linked to lower intake of protein, energy, iron and riboflavin.(6) While parasites like hookworm directly cause nutrient loss through blood and iron depletion, often resulting in anaemia. (1) Deficiencies in zinc, vitamin D and omega-3 fatty acids are common in children affected by malnutrition and parasitic infections. Zinc and vitamin D is essential for gut integrity, immune function, and growth, while omega-3 fatty acids support intestinal structure and have anti-inflammatory effects. Low levels of these nutrients may worsen intestinal dysfunction, including EED, and contribute to impaired growth.(9) In the light of the previously discussed mechanisms, a strong bidirectional relationship exists between parasitic infections and malnutrition, whereby each condition aggravates the other, forming a vicious cycle that increases the risk of stunting, poor growth, anaemia, and impaired immune function.(3)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07496801
Study groupRoleWhat they receive
Group Apatients with different forms of undernutrition
control groupnormal child

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. the prevelance of intestinal parasitic infections

    Determine the prevelance of intestinal parasitic infections in different forms of undernutrition children compared with normal controls.

    Measured: baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Mar 2026
  2. Study startApr 2026 (estimated)
  3. Primary completionApr 2027 (estimated)
  4. Study completionDec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
116 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07496801
Sponsor's protocol ID
Intestinal Parasitic Infection
Status last verified
Mar 2026
First submitted
23 Mar 2026
Last updated
27 Mar 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Malnourished Children, run by Assiut University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 27 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

the prevelance of intestinal parasitic infections (time frame: baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in